Evidence map›Paper›PMID 34989882›Full record

ArticleWorld journal of microbiology & biotechnology2022

Growth-phase specific regulation of cviI/R based quorum sensing associated virulence factors in Chromobacterium violaceum by linalool, a monoterpenoid.

Saptami Kanekar, Rekha Punchappady Devasya

Abstract read
PubMed Publisher
In one paragraph

Article in World journal of microbiology & biotechnology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Regulation of virulence inFrontiers in microbiology · 2024
    Review
  5. Combination of 2-mSphere · 2023
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Saptami KanekarMicrobiology and Biotechnology Division, Yenepoya Research Centre, Yenepoya (Deemed to be University), University Road, Deralakatte, Mangalore, Karnataka, 575018, India.
Rekha Punchappady DevasyaMicrobiology and Biotechnology Division, Yenepoya Research Centre, Yenepoya (Deemed to be University), University Road, Deralakatte, Mangalore, Karnataka, 575018, India. rekhapd@yenepoya.edu.in.ORCID http://orcid.org/0000-0002-9187-6395
Yenepoya University · IN

Funding

Indian Council of Medical Research 2019-5152/CMB/BMS
6 · The paper itself

Abstract

Quorum sensing (QS)-dependent gene regulation in bacteria performs a vital role in synchronization of cell-density-dependent functions. In Chromobacterium violaceum QS-dependent cviI/R regulatory genes are activated during the mid- or late-exponential phase of growth. However, sufficient evidence is lacking on the role of QS inhibitors on gene regulation at different phases of growth. Hence, we report the role of linalool, a natural monoterpenoid on QS mediated gene regulation at different stages of growth in C. violaceum by performing biosensor, growth kinetic and gene expression studies. In vitro and in vivo studies were performed for establishing role of linalool in reducing the virulence and infection by using HEK-293 T cell lines and Caenorhabditis elegans models respectively. C. violaceum CV026 with C

Indexed as

Virulence FactorsAcyclic MonoterpenesAnimalsAnti-Bacterial AgentsBiofilmsCaenorhabditis elegansChromobacteriumGene Expression Regulation, BacterialGram-Negative Bacterial InfectionsHEK293 CellsHumansMicrobial Sensitivity TestsMonoterpenesPlant ExtractsQuorum SensingVirulenceAcyclic MonoterpenesAnti-Bacterial AgentslinaloolMonoterpenesPlant ExtractsVirulence FactorscviI/R regulationC. violaceumIn vivo infectionLinaloolQuorum sensing

Identifiers

PMID34989882
OpenAlexW4205860006

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.